Category: Stem Cells therapy

Mesenchymal Stem Cells may be a viable treatment option for Post Treatment Lyme Disease Syndrome (PTLDS). Stem cells have been proven to have strong anti-inflammatory properties. Through the use of large cell quantity transplants, the youthful stem cells have a regulatory nature on the body

Stem Cell Therapy For Knees Mesenchymal stem cells (MSCs) are one of the main types used by physicians in treating knee joint problems. These cells live in bone marrow, but increasing evidence shows they also exist in Read more…

The area and underlying cause being treated generally influence the associated treatment cost because the procedure will need different cell counts, cell types, and treatment protocols. In general, the average cost of stem cell therapy Read more…

Cell therapy (also called cellular therapy, cell transplantation, or cytotherapy) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity

Stem cell therapy cost can range anywhere between $5000 – $50,000. Patients must do their research and ask as many questions as they can before financially committing to treatment. Patients must do their research and ask as Read more…

 In general, the average cost of stem cell therapy can range anywhere between $5k – $50k. Therefore, patients must do their homework and ask relevant questions before 

The average cost of stem cell therapy ranges from under $5,000 to over $25,000, depending the type and sources of the stem cells

With stem cell therapy being innovative and new, insurance may not cover the cost at a center providing this kind of revolutionary treatment. The big pharma industry is still going very strong, and it’s a lot easier for doctors Read more…

STEM CELL THERAPY IN GERMANY AND UKRAINE 2021 STEM CELL THERAPY IN GERMANY AND UKRAINE  Today in Ukraine, more than 5 clinics involved in stem cell treatment. In general about 2,000 professionals working in this Read more…

Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease To evaluate the safety and efficacy of human umbilical cord mesenchymal stem cells transplantation in patients with COPD

Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease Recent COVID 19 pandemic has overwhelmed health services all around the world, and humanity has yet to find a cure or a vaccine Read more…

Alzheimer’s Disease Stem Cells Multiple Infusions Brief Summary:The purpose of this research study is to test the safety, possible side effects, and possible effectiveness of mesenchymal stem cell infusions when given to people with a Read more…

The Safety/Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells Therapy for Lumbar Discogenic Pain This experimental use umbilical cord mesenchymal stem cells in treatment of the early stage of lumbar discogenic pain (endogenous pain Read more…

Autologous Stem Cell Transplantation for Crohn’s Disease Brief Summary:The objective of this study is to evaluate the safety and effectiveness of administering high-dose chemotherapy followed by infusion of autologous CD34-selected peripheral blood stem cells (PBSC) Read more…

Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B Detailed Description:The study is investigating the effect and safety of stem cells therapy in patients with liver cirrhosis that is specifically caused by Hepatitis Read more…

Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients Stem cell therapy has emerged as a revolutionary treatment for diseases that were considered untreatable only a few years ago. Umbilical cord-derived Read more…

Clinical Study of Adipose Derived Mesenchymal Stem Cells for Treatment of Pulmonary Arterial Hypertension Brief Summary:Pulmonary arterial hypertension is a disease characterised by pathological changes in the pulmonary arteries leading to a progressive increase in Read more…

The Safety/Efficacy of hUC Mesenchymal Stem Cells（19#iSCLife®-OA） Therapy for Patients With Osteoarthritis This is a random, open label, and parallel controled experiment. All patients are selected and sign consent forms, then divided into 3 groups. Read more…

hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis Cirrhosishepatitis Cirrhosis Detailed Description: This experimental use umbilical cord mesenchymal stem cells in treatment of decompensated hepatitis B cirrhosis to evaluate its safety and Read more…

Follow-up Study After ACLSCT for Restoration of Corneal Epithelium in Patients With LSCD Due to Ocular Burns (HOLOCORE-FU) This is a multinational, multicentre, prospective, non-pharmacological follow-up study of the clinical trial HOLOCORE. All patients transplanted Read more…

Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis This study primarily aimed to evaluate the safety of human embryonic stem cell (hESC)-derived mesenchyma stem cells in interstitial cystitis.

Limbal Stem Cell Deficiency The study ” Autologous cultured corneal epithelium (CECA) for the treatment of corneal lesions associated with limbal stem cell deficiency” is the first clinical trial of this product manufactured at the LOEX laboratory. Read more…

Mesenchymal Stem Cells for Progressive Multiple Sclerosis_Sweden To assess the safety of a single dose of IV infusion of bone-marrow derived autologous Mesenchymal Stem Cells (MSCs) in Multiple Sclerosis (MS) with progressive disease status.

Autologous Bone Marrow Stem Cell Therapy Combined With Psychological Therapy and Rehabilitation for Autism (ASPRA)

Treatment of COVID-19 Patients Using Wharton’s Jelly-Mesenchymal Stem Cells Brief Summary:The purpose of this study is to investigate the potential use of Wharton’s Jelly Mesenchymal stem cells (WJ-MSCs) for treatment of patient diagnosed with Corona Virus Read more…

A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS) from getting worse in 71% of people with relapsing-remitting MS for up to Read more…